StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)

Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –

Quest Diagnostics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Quest Diagnostics's price to book ratio was 3.9× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 2.2× to 3.9×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.9×+1.2
2025Dec 31, 20252.7×+0.2
2024Dec 31, 20242.5×+0.0
2023Dec 29, 20232.4×−0.6
2022Dec 30, 20223.0×−0.5
2021Dec 31, 20213.5×+1.0
2020Dec 31, 20202.5×−0.1
2019Dec 31, 20192.6×+0.4
2018Dec 31, 20182.2×−0.7
2017Dec 29, 20172.9×+0.1
2016Dec 30, 20162.8×+0.6
2015Dec 31, 20152.3×−0.1
2014Dec 31, 20142.3×+0.2
2013Dec 31, 20132.2×−0.1
2012Dec 31, 20122.2×−0.5
2011Dec 30, 20112.7×+0.2
2010Dec 31, 20102.5×+0.3
2009Dec 31, 20092.2×–

More Quest Diagnostics figures

See a number that looks wrong?